Gebbie Ailsa
Consultant Gynaecologist, Family Planning and Well Woman Services, Edinburgh.
J Br Menopause Soc. 2003 Sep;9(3):123-8. doi: 10.1258/136218003100322350.
The perimenopause is a stage of life when a woman has low fertility but still requires contraception. It is also a peak age for menstrual dysfunction and a time when menopausal symptoms may commence. All these factors impact on contraceptive choice. Combined oral contraception can be continued until the age of 50 years in women who are low risk and do not smoke. Progestogen-only methods have advantages for women who have risk factors for cardiovascular disease. An intrauterine device may exacerbate menstrual problems at this stage but the levonorgestrel releasing intrauterine system is highly effective in controlling perimenopausal menstrual dysfunction. Women should receive accurate individualised advice on how the risks and benefits of contraceptive methods relate to them and on when contraception can be safely discontinued. Hormone replacement therapy is not reliably contraceptive and women should be advised to continue with a contraceptive method until they have reached natural sterility.
围绝经期是女性生育能力较低但仍需避孕的生命阶段。它也是月经功能紊乱的高发年龄段,同时是更年期症状可能开始出现的时期。所有这些因素都会影响避孕方法的选择。对于低风险且不吸烟的女性,复方口服避孕药可以持续使用至50岁。仅含孕激素的避孕方法对有心血管疾病风险因素的女性具有优势。宫内节育器可能会在这个阶段加重月经问题,但左炔诺孕酮宫内缓释系统在控制围绝经期月经功能紊乱方面非常有效。女性应就避孕方法的风险和益处如何与自身相关以及何时可以安全停止避孕获得准确的个性化建议。激素替代疗法并非可靠的避孕方法,应建议女性继续采用避孕方法,直至达到自然绝经状态。